Last reviewed · How we verify
GET-73
At a glance
| Generic name | GET-73 |
|---|---|
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes (PHASE1, PHASE2)
- Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder (PHASE2)
- Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |